Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.480
+0.020 (0.58%)
At close: Apr 28, 2026, 4:00 PM EDT
3.540
+0.060 (1.73%)
Pre-market: Apr 29, 2026, 7:53 AM EDT
Eledon Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 22.81 | 20.55 | 4.61 | 56.41 | 84.83 | Upgrade
|
| Short-Term Investments | 110.53 | 119.63 | 46.49 | - | - | Upgrade
|
| Cash & Short-Term Investments | 133.34 | 140.18 | 51.1 | 56.41 | 84.83 | Upgrade
|
| Cash Growth | -4.88% | 174.31% | -9.41% | -33.51% | -25.71% | Upgrade
|
| Other Receivables | 0.51 | 0.63 | - | - | - | Upgrade
|
| Receivables | 0.51 | 0.63 | - | - | - | Upgrade
|
| Prepaid Expenses | 1.83 | 2.82 | 4.94 | 3.08 | 3.48 | Upgrade
|
| Other Current Assets | 0.01 | 0.1 | 0.09 | 0.03 | 0.03 | Upgrade
|
| Total Current Assets | 135.69 | 143.73 | 56.13 | 59.52 | 88.35 | Upgrade
|
| Property, Plant & Equipment | 0.61 | 0.93 | 0.37 | 0.74 | 0.77 | Upgrade
|
| Goodwill | - | - | - | - | 48.65 | Upgrade
|
| Other Intangible Assets | 32.39 | 32.39 | 32.39 | 32.39 | 32.39 | Upgrade
|
| Other Long-Term Assets | 0.32 | 0.36 | 0.19 | 0.15 | 0.4 | Upgrade
|
| Total Assets | 169.01 | 177.41 | 89.07 | 92.79 | 170.55 | Upgrade
|
| Accounts Payable | 3.63 | 5.83 | 0.97 | 2.2 | 1.81 | Upgrade
|
| Accrued Expenses | 14.36 | 5.43 | 2.55 | 3.91 | 2.22 | Upgrade
|
| Current Portion of Leases | 0.36 | 0.31 | 0.38 | 0.36 | 0.37 | Upgrade
|
| Total Current Liabilities | 18.34 | 11.58 | 3.9 | 6.48 | 4.4 | Upgrade
|
| Long-Term Leases | 0.28 | 0.64 | - | 0.38 | 0.4 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 2.19 | 2.18 | 1.75 | 1.75 | 1.75 | Upgrade
|
| Other Long-Term Liabilities | 11.42 | 44.87 | 76.21 | - | - | Upgrade
|
| Total Liabilities | 32.23 | 59.27 | 81.86 | 8.61 | 6.55 | Upgrade
|
| Common Stock | 55.77 | 55.75 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 482.19 | 417.95 | 326.59 | 287.03 | 278.88 | Upgrade
|
| Retained Earnings | -401.2 | -355.59 | -319.4 | -202.87 | -114.9 | Upgrade
|
| Comprehensive Income & Other | 0.02 | 0.03 | - | - | - | Upgrade
|
| Shareholders' Equity | 136.78 | 118.14 | 7.21 | 84.18 | 164 | Upgrade
|
| Total Liabilities & Equity | 169.01 | 177.41 | 89.07 | 92.79 | 170.55 | Upgrade
|
| Total Debt | 0.64 | 0.95 | 0.38 | 0.75 | 0.77 | Upgrade
|
| Net Cash (Debt) | 132.7 | 139.22 | 50.72 | 55.66 | 84.06 | Upgrade
|
| Net Cash Growth | -4.69% | 174.50% | -8.88% | -33.78% | -26.29% | Upgrade
|
| Net Cash Per Share | 1.62 | 2.86 | 2.06 | 3.90 | 5.67 | Upgrade
|
| Filing Date Shares Outstanding | 75.85 | 59.88 | 24.81 | 13.78 | 14.31 | Upgrade
|
| Total Common Shares Outstanding | 75.54 | 59.79 | 24.21 | 13.78 | 14.31 | Upgrade
|
| Working Capital | 117.34 | 132.15 | 52.23 | 53.04 | 83.95 | Upgrade
|
| Book Value Per Share | 1.81 | 1.98 | 0.30 | 6.11 | 11.46 | Upgrade
|
| Tangible Book Value | 104.39 | 85.75 | -25.18 | 51.8 | 82.96 | Upgrade
|
| Tangible Book Value Per Share | 1.38 | 1.43 | -1.04 | 3.76 | 5.80 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.